New study shows promise for treating COVID-19 patients with convalescent plasma
A new study may provide renewed hope for the treatment of COVID-19. Researchers at Johns Hopkins University have released the results of a 16-month nationwide study on convalescent plasma use on COVID-19 patients. The study found convalescent plasma reduced hospitalizations by 54%.
Joining Cincinnati Edition to discuss the results and talk about convalescent plasma treatment for COVID-19 patients here locally are Johns Hopkins University Associate Professor of Medicine Shmuel Shoham, M.D.; and Hoxworth Blood Center Chief Medical Officer David Oh, M.D.
Listen to Cincinnati Edition live at noon M-F. Audio for this segment will be uploaded after 4 p.m. ET.
Never miss an episode by subscribing to our podcast: